Form 4: Agilon Health Director Silvana Battaglia Reports Stock Transactions

Director Silvana Battaglia reports acquisition and disposal of Agilon Health (AGL) common stock and restricted stock units.

Summary

• On May 29, 2024, Silvana Battaglia, a director of Agilon Health, acquired 32,119 shares of common stock.
• These shares were acquired at a price of $0.
• Following this transaction, Battaglia directly owns 41,082 shares, which includes restricted stock units.
• The restricted stock units vest in full on May 29, 2025, contingent upon continued service as a director.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.

Future Outlook

The report indicates continued service as a director is required for the restricted stock units to vest, suggesting an ongoing relationship between the reporting person and the company.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. They are closely watched by investors for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a company director.

Key Dates